Reuters logo
21 days ago
BRIEF-Zhejiang Huahai Pharmaceutical unit receives approval for drug clinical trials
July 4, 2017 / 8:54 AM / 21 days ago

BRIEF-Zhejiang Huahai Pharmaceutical unit receives approval for drug clinical trials

1 Min Read

July 4 (Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd :

* Says its unit has been granted approval for drug clinical trials for recombinant human vascular endothelial growth factor receptor - antibody fusion protein eye injection issued by china food and drug administration

* Says it is mainly used for treatment of wet age-related macular degeneration

Source text in Chinese: goo.gl/xfzn7Q

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below